[1] 崔勤涛,曹银利,张杰,等. 冠心病易感性与血管内皮生长因子基因单核苷酸多态性的关系[J]. 中华实验外科杂志,2015,32(6):1443-1446. [2] Hokimoto S, Akasaka T, Tabata N, et al. Impact of esomeprazole on platelet reactivity and clinical outcome according to CYP2C19 genotype in coronary heart disease patients during dual antiplatelet therapy[J]. Thrombosis Res,2015,135(6):1081-1086. [3] Kim DA, Mcclure WG, Neighoff JB, et al. Platelet Response to Serotonin in Patients With Stable Coronary Heart Disease[J]. The Am J Card,2014,114(2):181-186. [4] Vogel S, Rath D, Lu J, et al. Elevated mitochondrial membrane potential of circulating monocyte–platelet aggregates in patients with coronary heart disease[J]. Int J Card,2015,181(05):135-137. [5] D'Anna C, Piscione F, De Luca G, et al. CRT-103 NSTEMI In Elderly Patients Treated With Early Revascularization: Long-term Outcome[J]. JACC: Card Int, 2015, 8(2S): S9-S9. [6] Ozcan KS, Ekmekci A, Gungor B, et al. Clinical use of serial mean platelet volume measurement for diagnosis of non-ST segment elevation myocardial infarction in patients visiting emergency department with acute chest pain[J]. Hong Kong J Emergency Med, 2015, 22(3): 180-181. [7] 潘亮,邱春光. 血管内皮功能障碍在冠心病发生发展中的作用[J]. 中国分子心脏病学杂志,2014,32(05):1106-1108. [8] 许文亮,丁华民,张纯全,等. 冠心病患者平均血小板体积影响因素[J]. 中华实用诊断与治疗杂志,2013,25(12):1238-1240.
2019, Vol. 36 
